Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index; 28 of the 50 sources its claims cite were checked for support.

The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial

Open access
Schäfer, Anna, Wendel, Julia, Franke, Isabella, Bauer, Armin, Baumeister, Harald, Bendig, Eileen, Brucker, Sara Y., Deutsch, Thomas M., Garatva, Patricia, Haas, Kirsten, Heil, Lorenz, Hügen, Klemens, Manger, Helena, Pryss, Rüdiger, Rücker, Viktoria, Salmen, Jessica, Szczesny, Andrea, Vogel, Carsten, Wallwiener, Markus, Wöckel, Achim, Heuschmann, Peter U., the BETTER-CARE Study Group, Ast, Alexander, Belke, Kerstin, Beurer, Björn, Bolkenius, Petra, Freese, Kristina, Frumkin, Nora, Gnauert, Karsten, Graf, Heiko, Hackmann, John, Hartmann, Corinna, Hesse, Tobias, Hopp, Melanie, Keil, Elke, Lehnert, Antje, Müller, Cordula, Mundhenke, Christoph, Niestroj, Hue Phan, Nixdorf, Antje, Pankert, Kilian, Perez, Sibylle, Radosa, Julia, Rezek, Daniela, Seldte, Jens-Paul, Stalzer, Gabriele, Sykorova, Zuzana, Tenger, Martin, Volmer, Léa, Würfel, Katharina, Zorr, Andreas · 2024 · Trials

Abstract

Background: The risk of breast cancer patients for long-term side effects of therapy such as neurotoxicity and cardiotoxicity as well as late effects regarding comorbidities varies from individual to individual. Personalised follow-up care concepts that are tailored to individual needs and the risk of recurrences, side effects and late effects are lacking in routine care in Germany. Methods: We describe the methodology of BETTER-CARE, a parallel-arm cluster-randomised controlled trial conducted at 15 intervention and 15 control centres, aiming to recruit 1140 patients, and the results of the pilot phase. The needs- and risk-adapted complex intervention, based on existing development frameworks, includes a multidisciplinary network and digital platforms for symptom and need documentation and just-in-time adaptive interventions. The control group comprises usual care according to clinical guidelines. The primary outcome is health-related quality of life (EORTC QLQ-C30 global health), and secondary outcomes include treatment adherence. Results: The 2-month pilot phase comprising 16 patients in one intervention and one control pilot centre demonstrated the feasibility of the BETTER-CARE approach. Discussion: BETTER-CARE is a feasible intervention and study concept, investigating individualised needs- and risk-adapted breast cancer follow-up care in Germany. If successful, the approach could be implemented in German routine care. Trial registration: German Clinical Trial Register DRKS00028840. Registered on April 2022. © The Author(s) 2024.

Overview

CoChat Summary

TL;DR

BETTER-CARE is a cluster-randomised, needs- and risk-adapted breast cancer follow-up programme in Germany that combines a multidisciplinary network, electronic records, phone-based assessment, and digital apps. A 2-month pilot with 16 patients found the approach feasible, supporting progression to the main trial.

Key findings

  • The main trial is a parallel-arm cluster-randomised controlled trial with 30 centres (15 intervention, 15 control) aiming to recruit 1140 patients; the study runs from March 2023 until June 2025.
  • In the 2-month pilot phase, 16 patients were recruited (7 intervention, 9 control), and the authors report that this “demonstrated the feasibility” of the BETTER-CARE approach.
  • Pilot app testing suggested acceptable usability: the PIA Health app had a median uMARS-G score of 4.3 (range 3.7–4.4); 3 participants used it at least five times, 1 used it less frequently, and 1 not at all.
  • Process indicators in the pilot showed partial engagement with other components: 5 of 7 intervention patients completed the online survey on intervention components, and 1 participant was prompted to further treatment by the needs-assessment phone call.

Methods

  • Design: Parallel-arm cluster-randomised controlled trial with Breast Cancer Centres as clusters; 30 centres were selected after inviting 181, with randomisation to 15 intervention and 15 control centres.
  • Sample/data: Eligible participants were breast cancer patients aged 18+ at the end of curative primary treatment, excluding metastatic disease, lack of digital infrastructure, or participation in another digital follow-up programme. Pilot feasibility testing included 16 patients from one intervention and one control pilot centre.
  • Main analysis: The planned primary analysis uses a linear mixed effects model for the EORTC QLQ-C30 global health status/QoL outcome at 12 months, with centre as a random effect; analyses are modified intention-to-treat, with secondary multivariable and sensitivity analyses.

Limitations

  • The paper states that the pilot phase was small and had a short follow-up duration, limiting what could be tested.
  • The pilot had too few intervention patients to test referral from the PIA Health app to the ACTonCancer intervention because no patient exceeded the predefined cut-off.
  • The authors note that only a small number of responses were obtained from relatives and gynaecologists in private practice, limiting conclusions about those groups.
  • The text also makes evident that there is a potential self-selection bias because three centres dropped out after randomisation and were replaced, and the authors explicitly say a self-selection bias cannot be ruled out.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13063-024-08614-8

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Schedule of enrolment, interventions, and assessments of the BETTER-CARE trial
Fig. 1 Schedule of enrolment, interventions, and assessments of the BETTER-CARE trialCC BY · PubMed Central
Fig. 2 Trial course of control and intervention group in the BETTER-CARE trial. QLQ-FA-12, EORTC Quality of Life Module Measuring Cancer Related Fatigue; GAD-7, Generalised Anxiety Disorder 7-Item; PHQ-8, Patient Health Questionnaire 8-Item
Fig. 2 Trial course of control and intervention group in the BETTER-CARE trial. QLQ-FA-12, EORTC Quality of Life Module Measuring Cancer Related Fatigue; GAD-7, Generalised Anxiety Disorder 7-Item; PHQ-8, Patient Health Questionnaire 8-ItemCC BY · PubMed Central
Fig. 3 The 30 participating centres of the BETTER-CARE trial: 15 intervention and 15 control regions. The graphic was created with R version 4.2.2 ©2022 The R Foundation for Statistical Computing, packages maps and mapadata
Fig. 3 The 30 participating centres of the BETTER-CARE trial: 15 intervention and 15 control regions. The graphic was created with R version 4.2.2 ©2022 The R Foundation for Statistical Computing, packages maps and mapadataCC BY · PubMed Central

Verification

Claims the paper makes

15 Valid · 2 Not valid · 7 Not checked · 78 Own results and interpretations

10 more claims

Create a free account to see all 102 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 70
  • It may state two separate claims as one. 38

Create a free account to see these claims.

Citations

Cites

Show all 52 references

Research works printed but not linked: 2

  1. Medical Research Council. A framework for the development and evaluation of RCTs for complex interventions to improve health. London: MRC; 2000.
  2. Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. EORTC QLQ-C30 Scoring Manual (3rd edition). Brussels: EORTC; 2001.

Cited by

See all 3

Metadata

Authors
Schäfer, A., Wendel, J., Franke, I., Bauer, A., Baumeister, H., Bendig, E., Brucker, S. Y., Deutsch, T. M., Garatva, P., Haas, K., Heil, L., Hügen, K., Manger, H., Pryss, R., Rücker, V., Salmen, J., Szczesny, A., Vogel, C., Wallwiener, M., Wöckel, A., Heuschmann, P. U., the BETTER-CARE Study Group, Ast, A., Belke, K., Beurer, B., Bolkenius, P., Freese, K., Frumkin, N., Gnauert, K., Graf, H., Hackmann, J., Hartmann, C., Hesse, T., Hopp, M., Keil, E., Lehnert, A., Müller, C., Mundhenke, C., Niestroj, H. P., Nixdorf, A., Pankert, K., Perez, S., Radosa, J., Rezek, D., Seldte, J.-P., Stalzer, G., Sykorova, Z., Tenger, M., Volmer, L., Würfel, K., & Zorr, A.
Affiliations
  • University of Würzburg (DE)
  • Universitätsklinikum Würzburg (DE)
  • Universität Ulm (DE)
  • Universitäts Frauenklinik (DE)
  • University Hospital Heidelberg (DE)
  • University Hospital in Halle (DE)
Venue
Trials
Published
2024-11-14
Volume
25
Issue
1
Pages
767-767
ISSN
1745-6215 (ISSN-L)
OpenAlex
W4404374384
Cited by
3
References
52
Citations by year
2026: 2 · 2025: 1
FWCI
0.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Trials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by)
  • Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Julius-Maximilians-Universität Würzburg
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Keywords
breast cancer, follow-up care, late effects of cancer treatment, neurotoxicity, cardiotoxicity, health-related quality of life, medication adherence, just-in-time adaptive interventions, digital platforms, multidisciplinary care network
MeSH terms
Aftercare, Breast Neoplasms, Feasibility Studies, Female, Germany, Humans, Middle Aged, Pilot Projects, Quality of Life, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial. https://app.cochat.ai/papers/10.1186/s13063-024-08614-8
The paper
Schäfer, A., Wendel, J., Franke, I., Bauer, A., Baumeister, H., Bendig, E., Brucker, S. Y., Deutsch, T. M., Garatva, P., Haas, K., Heil, L., Hügen, K., Manger, H., Pryss, R., Rücker, V., Salmen, J., Szczesny, A., Vogel, C., Wallwiener, M., . . . Zorr, A. (2024). The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial. Trials. https://doi.org/10.1186/s13063-024-08614-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.